Rachel A Brown, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 50 N Portland St, Fond Du Lac, WI 54935 Phone: 920-906-5100 |
Jeannette Sroka, RN Registered Nurse - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 23 W Scott St, Fond Du Lac, WI 54935 Phone: 920-926-0101 Fax: 920-926-0060 |
Cassandra Fink, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 480 Thomas St, Fond Du Lac, WI 54935 Phone: 920-517-2432 |
Miss Isabella Shafer, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 389 S Park Ave, Fond Du Lac, WI 54935 Phone: 920-539-4215 |
Charissa Doolittle, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 459 E 1st St, Fond Du Lac, WI 54935 Phone: 920-929-3542 Fax: 920-929-3129 |
Yvette Marie Teichmiller-hewitt, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 417 N National Ave, Fond Du Lac, WI 54935 Phone: 920-517-4675 |
April Riggs, PMHNP-BC Registered Nurse - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-4200 Fax: 920-926-8933 |
Nicole Mae Mata, R.N. Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: N6654 Rolling Meadows Dr, Fond Du Lac, WI 54937 Phone: 920-906-5100 |
Stacie Peterson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 50 N Portland St, Fond Du Lac, WI 54935 Phone: 920-906-5144 |
Kimberly Ketter, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: W5451 Abel Dr, Fond Du Lac, WI 54937 Phone: 920-251-3494 |
Patrick Louis Sorensen, RN Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: N6654 Rolling Meadows Dr, Fond Du Lac, WI 54937 Phone: 920-906-5100 |
Sheri A Smit, RN Registered Nurse - Registered Nurse First Assistant Medicare: Not Enrolled in Medicare Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 |
Carrie A Rothering, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 210 Wisconsin American Dr, Fond Du Lac, WI 54937 Phone: 920-926-7800 |
Connie J Milton, RN Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: N6654 Rolling Meadows Dr, Fond Du Lac, WI 54937 Phone: 920-906-5100 |
Krissy K Vang, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 290 Muenter Ave, Fond Du Lac, WI 54935 Phone: 920-517-3461 |
Jodene Hewitt, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: N7720 County Road Wh, Fond Du Lac, WI 54937 Phone: 920-960-1793 Fax: 920-926-2722 |
Mrs. Marne Kelley Osborn, Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: N6654 Rolling Meadows Dr, Fond Du Lac, WI 54937 Phone: 920-906-5100 |
Barbara Verhaalen De Sotelo, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 50 N Portland St, Fond Du Lac, WI 54935 Phone: 920-906-5192 |
Laureen Wiest, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 323 E Division St, Fond Du Lac, WI 54935 Phone: 608-577-8357 |
Sally Bowman, Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: N6654 Rolling Meadows Dr, Fond Du Lac, WI 54937 Phone: 920-906-5100 |
News Archive
According to a new study published in the medical journal The Lancet on Tuesday, two antidepressants that are commonly given to Alzheimer's disease patients appear not only to be ineffective but may give side effects such as nausea and drowsiness. Researchers urged doctors to think twice before prescribing these drugs to Alzheimer's patients with depression.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has revealed new results from a global survey demonstrating that 66% of patients with metastatic colorectal cancer (mCRC) are now tested for KRAS to determine if they could benefit from a personalized therapy, such as Erbitux® (cetuximab). This represents a 50% increase in levels of KRAS testing in just one year.
Optimer Pharmaceuticals, Inc. today announced the pricing of a previously announced underwritten public offering of 6,000,000 shares of its common stock, offered at a price to the public of $11.25 per share. The gross proceeds to Optimer from this offering are expected to be $67.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Optimer.
The widespread use of a simplified clinical tool to estimate future coronary risk could lead to the classification of millions of Americans into different risk groups than when using the original, "gold-standard" tool. Millions of patients may have been misclassified into higher-risk groups and therefore potentially over-treated, while others may have ended up in lower-risk groups and therefore potentially under-treated for heart disease. The study-, led by William Gordon from Weill Cornell Medical College in the US and colleagues, is published in the Journal of General Internal Medicine-, published by Springer.
› Verified 7 days ago